FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968331373> ?p ?o ?g. }

• W1968331373 endingPage "1814" @default.
• W1968331373 startingPage "1809" @default.
• W1968331373 abstract "In Brief Purpose: To analyze intraocular growth factor and cytokine concentrations in eyes with different stages of age-related macular degeneration (AMD) compared with controls. Methods: The Clinical Age-Related Maculopathy Staging (CARMS) system was used for assignment of patients into the respective categories. Aqueous humor specimens were taken before cataract surgery in 21 controls (CARMS 1) and in 17 early (CARMS 2) and 16 intermediate (CARMS 3) AMD patients. In 18 neovascular (CARMS 5) AMD patients, specimens were taken immediately before anti–vascular endothelial growth factor intravitreal therapy. Luminex multiplex bead assays were conducted for endostatin, angiogenin, vascular endothelial growth factor, platelet-derived growth factor AA, placental growth factor, thrombospondin 2, and fibroblast growth factor a. Results: Vascular endothelial growth factor concentrations were elevated in CARMS 3 (P = 0.037) and tended to be elevated in CARMS 5 (P = 0.093), whereas levels in CARMS 2 (P = 0.425) were similar to CARMS 1. Platelet-derived growth factor levels were diminished in CARMS 2 (P = 0.020), with a trend to lower levels for CARMS 3 (P = 0.099) and CARMS 5 (P = 0.082) compared with CARMS 1. For CARMS 5, antiangiogenic endostatin was elevated (P < 0.002), while antiangiogenic thrombospondin 2 was reduced (P = 0.029). Conclusion: Clinical Age-Related Maculopathy Staging 3 dry AMD was associated with higher vascular endothelial growth factor levels than CARMS 5 neovascular AMD. Therefore, intraocular vascular endothelial growth factor concentrations do not seem to reflect choroidal neovascularization activity in neovascular AMD directly. Platelet-derived growth factor was decreased in most forms of AMD. The antiangiogenic endostatin was exclusively elevated in neovascular AMD, while thrombospondin 2 was reduced. Age-related macular degeneration disease seems to be associated with a generally altered cytokine system. Higher vascular endothelial growth factor levels were found in intermediate dry age-related macular degeneration (AMD) than in active neovascular AMD compared with controls. Reduced platelet-derived growth factor (PDGF) levels were associated with most forms of AMD, whereas endostatin was exclusively elevated in neovascular AMD. Age-related macular degeneration disease seems to be associated with an altered cytokine system." @default.
• W1968331373 created "2016-06-24" @default.
• W1968331373 creator A5017191026 @default.
• W1968331373 creator A5029426446 @default.
• W1968331373 creator A5034780611 @default.
• W1968331373 creator A5070523404 @default.
• W1968331373 creator A5085855365 @default.
• W1968331373 creator A5086630551 @default.
• W1968331373 date "2013-10-01" @default.
• W1968331373 modified "2023-09-23" @default.
• W1968331373 title "INTRAOCULAR GROWTH FACTORS AND CYTOKINES IN PATIENTS WITH DRY AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION" @default.
• W1968331373 cites W1484703211 @default.
• W1968331373 cites W1487528435 @default.
• W1968331373 cites W1974361339 @default.
• W1968331373 cites W1983896293 @default.
• W1968331373 cites W1988077870 @default.
• W1968331373 cites W2001825182 @default.
• W1968331373 cites W2037780881 @default.
• W1968331373 cites W2039150416 @default.
• W1968331373 cites W2039730121 @default.
• W1968331373 cites W2043057909 @default.
• W1968331373 cites W2051149451 @default.
• W1968331373 cites W2053123102 @default.
• W1968331373 cites W2062675409 @default.
• W1968331373 cites W2064892180 @default.
• W1968331373 cites W2069110097 @default.
• W1968331373 cites W2074174427 @default.
• W1968331373 cites W2075634939 @default.
• W1968331373 cites W2080591818 @default.
• W1968331373 cites W2129170976 @default.
• W1968331373 cites W2154711032 @default.
• W1968331373 cites W2313043717 @default.
• W1968331373 doi "https://doi.org/10.1097/iae.0b013e318285cd9e" @default.
• W1968331373 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23492946" @default.
• W1968331373 hasPublicationYear "2013" @default.
• W1968331373 type Work @default.
• W1968331373 sameAs 1968331373 @default.
• W1968331373 citedByCount "35" @default.
• W1968331373 countsByYear W19683313732013 @default.
• W1968331373 countsByYear W19683313732014 @default.
• W1968331373 countsByYear W19683313732015 @default.
• W1968331373 countsByYear W19683313732016 @default.
• W1968331373 countsByYear W19683313732017 @default.
• W1968331373 countsByYear W19683313732018 @default.
• W1968331373 countsByYear W19683313732020 @default.
• W1968331373 countsByYear W19683313732021 @default.
• W1968331373 countsByYear W19683313732023 @default.
• W1968331373 crossrefType "journal-article" @default.
• W1968331373 hasAuthorship W1968331373A5017191026 @default.
• W1968331373 hasAuthorship W1968331373A5029426446 @default.
• W1968331373 hasAuthorship W1968331373A5034780611 @default.
• W1968331373 hasAuthorship W1968331373A5070523404 @default.
• W1968331373 hasAuthorship W1968331373A5085855365 @default.
• W1968331373 hasAuthorship W1968331373A5086630551 @default.
• W1968331373 hasConcept C106812560 @default.
• W1968331373 hasConcept C118487528 @default.
• W1968331373 hasConcept C126322002 @default.
• W1968331373 hasConcept C134018914 @default.
• W1968331373 hasConcept C146285616 @default.
• W1968331373 hasConcept C167734588 @default.
• W1968331373 hasConcept C170493617 @default.
• W1968331373 hasConcept C2775960820 @default.
• W1968331373 hasConcept C2776403814 @default.
• W1968331373 hasConcept C2776719180 @default.
• W1968331373 hasConcept C2776871010 @default.
• W1968331373 hasConcept C2777025900 @default.
• W1968331373 hasConcept C2778271429 @default.
• W1968331373 hasConcept C2779059073 @default.
• W1968331373 hasConcept C2780394083 @default.
• W1968331373 hasConcept C2780428090 @default.
• W1968331373 hasConcept C2780827179 @default.
• W1968331373 hasConcept C71924100 @default.
• W1968331373 hasConcept C75920679 @default.
• W1968331373 hasConceptScore W1968331373C106812560 @default.
• W1968331373 hasConceptScore W1968331373C118487528 @default.
• W1968331373 hasConceptScore W1968331373C126322002 @default.
• W1968331373 hasConceptScore W1968331373C134018914 @default.
• W1968331373 hasConceptScore W1968331373C146285616 @default.
• W1968331373 hasConceptScore W1968331373C167734588 @default.
• W1968331373 hasConceptScore W1968331373C170493617 @default.
• W1968331373 hasConceptScore W1968331373C2775960820 @default.
• W1968331373 hasConceptScore W1968331373C2776403814 @default.
• W1968331373 hasConceptScore W1968331373C2776719180 @default.
• W1968331373 hasConceptScore W1968331373C2776871010 @default.
• W1968331373 hasConceptScore W1968331373C2777025900 @default.
• W1968331373 hasConceptScore W1968331373C2778271429 @default.
• W1968331373 hasConceptScore W1968331373C2779059073 @default.
• W1968331373 hasConceptScore W1968331373C2780394083 @default.
• W1968331373 hasConceptScore W1968331373C2780428090 @default.
• W1968331373 hasConceptScore W1968331373C2780827179 @default.
• W1968331373 hasConceptScore W1968331373C71924100 @default.
• W1968331373 hasConceptScore W1968331373C75920679 @default.
• W1968331373 hasIssue "9" @default.
• W1968331373 hasLocation W19683313731 @default.
• W1968331373 hasLocation W19683313732 @default.
• W1968331373 hasOpenAccess W1968331373 @default.
• W1968331373 hasPrimaryLocation W19683313731 @default.
• W1968331373 hasRelatedWork W1534760353 @default.

• next